Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
SP Kerkar, P Muranski, A Kaiser, A Boni… - Cancer research, 2010 - AACR
T-cell–based immunotherapies can be effective in the treatment of large vascularized
tumors, but they rely on adoptive transfer of substantial numbers (∼ 20 million) of tumor …
tumors, but they rely on adoptive transfer of substantial numbers (∼ 20 million) of tumor …
Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts
SP Kerkar, P Muranski, A Kaiser, A Boni… - Cancer …, 2010 - pubmed.ncbi.nlm.nih.gov
T-cell-based immunotherapies can be effective in the treatment of large vascularized tumors,
but they rely on adoptive transfer of substantial numbers (approximately 20 million) of tumor …
but they rely on adoptive transfer of substantial numbers (approximately 20 million) of tumor …
[引用][C] Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
SP KERKAR, P MURANSKI… - Cancer research …, 2010 - pascal-francis.inist.fr
Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in
Lymphodepleted Hosts CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Lymphodepleted Hosts CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
[HTML][HTML] Tumor-specific CD8+ T cells expressing IL-12 eradicate established cancers in lymphodepleted hosts
SP Kerkar, P Muranski, A Kaiser, A Boni… - Cancer …, 2010 - ncbi.nlm.nih.gov
T-cell based immunotherapies can be effective in the treatment of large vascularized tumors,
but they rely on adoptive transfer of substantial numbers (~ 20 million) of tumor-specific T …
but they rely on adoptive transfer of substantial numbers (~ 20 million) of tumor-specific T …
[PDF][PDF] Tumor-Specific CD8 (+) T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
A Kaiser, DC Palmer, L Gattinoni, NP Restifo - 2010 - Citeseer
T-cell–based immunotherapies can be effective in the treatment of large vascularized
tumors, but they rely on adoptive transfer of substantial numbers (∼ 20 million) of tumor …
tumors, but they rely on adoptive transfer of substantial numbers (∼ 20 million) of tumor …
[PDF][PDF] T Cells Expressing Interleukin-12+ Tumor-Specific CD8
2010 - researchgate.net
T-cell–based immunotherapies can be effective in the treatment of large vascularized
tumors, but they rely on adoptive transfer of substantial numbers (∼ 20 million) of tumor …
tumors, but they rely on adoptive transfer of substantial numbers (∼ 20 million) of tumor …
Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts.
SP Kerkar, P Muranski, A Kaiser, A Boni… - Cancer …, 2010 - europepmc.org
T-cell based immunotherapies can be effective in the treatment of large vascularized tumors,
but they rely on adoptive transfer of substantial numbers (~ 20 million) of tumor-specific T …
but they rely on adoptive transfer of substantial numbers (~ 20 million) of tumor-specific T …
Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hosts
SP Kerkar, P Muranski, A Kaiser, A Boni… - Cancer …, 2010 - pure.johnshopkins.edu
T-cell-based immunotherapies can be effective in the treatment of large vascularized tumors,
but they rely on adoptive transfer of substantial numbers (∼ 20 million) of tumor-specific T …
but they rely on adoptive transfer of substantial numbers (∼ 20 million) of tumor-specific T …
Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
SP Kerkar, P Muranski, A Kaiser, A Boni… - Cancer …, 2010 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> T-cell–based immunotherapies can be
effective in the treatment of large vascularized tumors, but they rely on adoptive transfer of …
effective in the treatment of large vascularized tumors, but they rely on adoptive transfer of …
[引用][C] Tumor-specific CD8^+ T cells expressing interleukin 12 eradicate established cancers in lymphodepleted hosts
K SP - Cancer Res., 2010 - cir.nii.ac.jp
Tumor-specific CD8^+ T cells expressing interleukin 12 eradicate established cancers in
lymphodepleted hosts | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …
lymphodepleted hosts | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …